Cost-effectiveness of cataract surgery in Japan

Japanese Journal of Ophthalmology

Volumn 55, Issue 4, 2011, Pages 333-342

  Hiratsuka, Yoshimune ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Cataract surgery; Cost effectiveness; Cost utility; QALYs; Time tradeoff

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EYE SURGERY; FEMALE; HEALTH CARE COST; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CATARACT; CATARACT EXTRACTION; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SICKNESS IMPACT PROFILE; VISUAL ACUITY;

EID: 80054743197     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0041-3     Document Type: Article

References (39)

1. Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ. Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada. JAMA. 2009;302:1437-43
2. Kane RC. Comparative effectiveness and health care spending. N Engl J Med. 2010;362:1845-6
3. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844-51 (Pubitemid 39573742)
4. Ellwein LB, Urato CJ. Use of eye care and associated charges among the Medicare population: 1991-1998. Arch Ophthalmol. 2002;120:804-11 (Pubitemid 34620361)
5. Ministry of Health, Labour and Welfare, Japanese Government. Survey of Medical Care Activities in Public Health Insurance 2008. Statistics and Information Department, Minister's Secretariat, 2009
6. Ministry of Health, Labour and Welfare, Japanese Government. National Medical Care Expenditure Estimates FY2007. Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. 2009. http://www.mhlw.go.jp/ toukei/saikin/hw/k-iryohi/07/toukei6.html. Accessed 7 July 2010
7. Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, Takano S, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17:50-7
8. Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002;109:606-12 (Pubitemid 34184933)
9. Kobelt G, Lundström M, Stenevi U. Cost-effectiveness of cataract surgery. Method to assess cost-effectiveness using registry data. J Cataract Refract Surg. 2002;28:1742-9 (Pubitemid 35204626)
10. Räsänen P, Krootila K, Sintonen H, Leivo T, Koivisto AM, Ryynänen OP, et al. Cost-utility of routine cataract surgery. Health Qual Life Outcomes. 2006;74:1-11
11. Lansingh VC, Carter MJ, Martens M. Global cost-effectiveness of cataract surgery. Ophthalmology. 2007;114:1670-8 (Pubitemid 47332658)
12. Takura T, Oshika T, Miyake K, Ozawa T, Yamashita H. Socioeconomic evaluation of cataract and intraocular lens surgery by cost-rate and cost-utility analysis. Jpn J Ophthalmol Surg. 2009; 22:67-76 (in Japanese)
13. Naeim A, Keeler EB, Gutierrez PR, Wilson MR, Reuben D, Mangione CM. Is cataract surgery cost-effective among older patients with a low predicted probability for improvement in reported visual functioning? Med Care. 2006;44:982-9 (Pubitemid 44679690)
14. Brown MM, Brown GC, Sharma S. Evidence-based to valuebased medicine. Chicago: American Medical Association Press; 2005
15. Euro Qol Group. EuroQol; a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208
16. Japanese EuroQol Translation Team. The development of the Japanese EuroQol instrument. J Health Care Soc. 1998; 8:109-23 (in Japanese)
17. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375-84 (Pubitemid 32675379)
18. Noto S, Uemura T. An improvement of a Health Utility Score by rehabilitation and the validity of the Japanese version Health Utility Index. Jpn J Health Econ Policy. 2009; 2:73-83 (in Japanese)
19. Oshika T, Nagahara K, Yaguchi S, Emi K, Takenaka H, Tsuboi S, et al. Three year prospective, randomized evaluation of intraocular lens implantation through 3.2 and 5.5 mm incisions. J Cataract Refract Surg. 1998;24:509-14 (Pubitemid 30195930)
20. Hanazaki H. The shape of optic edge and posterior cataract in silicone intraocular lens. Jpn J Ophthalmic Surg. 2004; 17:75-8 (in Japanese)
21. Kurosaka D, Oguchi Y, Hosaka D, Kitahara K. Clinical evaluation of soft acrylic colored intraocular lens (AANV). IOL&RS. 2005; 19:331-8 (in Japanese)
22. Matsumoto C, Iwanishi R, Saito K. Cataract surgery at the Miyoshi Kosei Hospital. Jpn Rev Clin Ophthalmol. 2007; 101:285-9 (in Japanese)
23. Takeshita T. Comparison of outcome after implantation of two intraocular lenses with same design and different material. Jpn J Clin Ophthalmol. 2007; 61:399-401 (in Japanese)
24. Yoshida S, Meya C, Okada Y, Matsushima H, Senoo T. The results of the intraocular lens for micro incision cataract surgery. Jpn J Ophthalmol Surg. 2009; 22:231-4 (in Japanese)
25. Abridged life tables for 2008 in Japan. http://www.mhlw.go.jp/ toukei/saikin/hw/life/life08/index.html. Accessed 7 July 2010
26. Lansingh VC, Carter MJ. Use of global visual acuity data in a time trade-off approach to calculate the cost utility of cataract surgery. Arch Ophthalmol. 2009;127:1183-93
27. Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110:2310-7 (Pubitemid 37485160)
28. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med. 2003;163:1637-41 (Pubitemid 36898950)
29. Detsky AS, Laupacis A. Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA. 2007;298:221-4 (Pubitemid 47057770)
30. Brown GC, Brown MM, Sharma S, Beauchamp G, Hollands H. The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc. 2001;99:199-203
31. Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol. 2002;86:493-6 (Pubitemid 34454489)
32. Tengs TO, Wallace A. A thousand health-related quality-of-life estimates. Med Care. 2000;38:583-637
33. Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care. 2007;45:1162-70
34. Garster NC, Palta M, Sweitzer NK, Kaplan RM, Fryback DG. Measuring health-related quality of life in population-based studies of coronary heart disease: Comparing six generic indexes and a disease-specific proxy score. Qual Life Res. 2009;18:1239-47
35. Brazier J. Valuing health states for use in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:769-79
36. Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A. Health utility values associated with diabetic retinopathy. Diabet Med. 2008;25:618-24 (Pubitemid 351590891)
37. Czoski-Murray C, Carlton J, Brazier J, Young T, Papo NL, Kang HK. Valuing condition-specific health states using simulation contact lenses. Value Health. 2009;12:793-9
38. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473-511 (Pubitemid 30106064)
39. Lundström M, Wendel E. Duration of self assessed benefit of cataract extraction: A long term study. Br J Ophthalmol. 2005;89:1017-20. (Pubitemid 41081416)